Cargando…
Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients
BACKGROUND: Hypermetabolism and hyposomatotropism related to severe burns lead to impaired wound healing. Growth hormone (GH) boosts wound healing notably following stimulation of the production of insulin-like growth factor-1 (IGF1), a mitogen factor for keratinocytes. Gamma-hydroxybutyrate (GHB) s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093961/ https://www.ncbi.nlm.nih.gov/pubmed/25024938 http://dx.doi.org/10.4103/2229-5151.134150 |
_version_ | 1782325782830383104 |
---|---|
author | Rousseau, Anne-Françoise Bargues, Laurent Bever, Hervé Le Vest, Philippe Cavalier, Etienne Ledoux, Didier Piérard, Gérald E. Damas, Pierre |
author_facet | Rousseau, Anne-Françoise Bargues, Laurent Bever, Hervé Le Vest, Philippe Cavalier, Etienne Ledoux, Didier Piérard, Gérald E. Damas, Pierre |
author_sort | Rousseau, Anne-Françoise |
collection | PubMed |
description | BACKGROUND: Hypermetabolism and hyposomatotropism related to severe burns lead to impaired wound healing. Growth hormone (GH) boosts wound healing notably following stimulation of the production of insulin-like growth factor-1 (IGF1), a mitogen factor for keratinocytes. Gamma-hydroxybutyrate (GHB) stimulates endogenous GH secretion. AIM: To assess effects of GHB sedation on keratinocytes proliferation (based on immunohistochemical techniques). DESIGN: Monocentric, prospective, controlled trial. MATERIALS AND METHODS: Patients (aging 18-65 years, burn surface area >30%, expected to be sedated for at least one month) were alternately allocated, at the 5(th) day following injury, in three groups according to the intravenous GHB dose administered for 21 days: Evening bolus of 50 mg/kg (Group B), continuous infusion at the rate of 10 mg/kg/h (Group C), or absence of GHB (Group P). They all received local standard cares. Immunohistochemistry (Ki67/MIB-1, Ulex europaeus agglutinin-1 and Mac 387 antibodies) was performed at D21 on adjacent unburned skin sample for assessing any keratinocyte activation. Serum IGF1 levels were measured at initiation and completion of the protocol. STATISTICAL ANALYSIS: Categorical variables were compared with Chi-square test. Comparisons of medians were made using Kruskal-Wallis test. Post hoc analyses were performed using Mann-Whitney test with Bonferroni correction for multiple comparisons. A P < 0.05 was considered to be statistically significant. RESULTS: A total of 14 patients completed the study (Group B: n = 5, Group C: n = 5, Group P: n = 4). Continuous administration of GHB was associated with a significant higher Ki67 immunolabeling at D21 (P = 0.049) and with a significant higher increase in the IGF1 concentrations at D21 (P = 0.024). No adverse effects were disclosed. CONCLUSIONS: Our preliminary data support a positive effect of GHB on keratinocyte proliferation and are encouraging enough to warrant large prospective studies. |
format | Online Article Text |
id | pubmed-4093961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-40939612014-07-14 Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients Rousseau, Anne-Françoise Bargues, Laurent Bever, Hervé Le Vest, Philippe Cavalier, Etienne Ledoux, Didier Piérard, Gérald E. Damas, Pierre Int J Crit Illn Inj Sci Original Article BACKGROUND: Hypermetabolism and hyposomatotropism related to severe burns lead to impaired wound healing. Growth hormone (GH) boosts wound healing notably following stimulation of the production of insulin-like growth factor-1 (IGF1), a mitogen factor for keratinocytes. Gamma-hydroxybutyrate (GHB) stimulates endogenous GH secretion. AIM: To assess effects of GHB sedation on keratinocytes proliferation (based on immunohistochemical techniques). DESIGN: Monocentric, prospective, controlled trial. MATERIALS AND METHODS: Patients (aging 18-65 years, burn surface area >30%, expected to be sedated for at least one month) were alternately allocated, at the 5(th) day following injury, in three groups according to the intravenous GHB dose administered for 21 days: Evening bolus of 50 mg/kg (Group B), continuous infusion at the rate of 10 mg/kg/h (Group C), or absence of GHB (Group P). They all received local standard cares. Immunohistochemistry (Ki67/MIB-1, Ulex europaeus agglutinin-1 and Mac 387 antibodies) was performed at D21 on adjacent unburned skin sample for assessing any keratinocyte activation. Serum IGF1 levels were measured at initiation and completion of the protocol. STATISTICAL ANALYSIS: Categorical variables were compared with Chi-square test. Comparisons of medians were made using Kruskal-Wallis test. Post hoc analyses were performed using Mann-Whitney test with Bonferroni correction for multiple comparisons. A P < 0.05 was considered to be statistically significant. RESULTS: A total of 14 patients completed the study (Group B: n = 5, Group C: n = 5, Group P: n = 4). Continuous administration of GHB was associated with a significant higher Ki67 immunolabeling at D21 (P = 0.049) and with a significant higher increase in the IGF1 concentrations at D21 (P = 0.024). No adverse effects were disclosed. CONCLUSIONS: Our preliminary data support a positive effect of GHB on keratinocyte proliferation and are encouraging enough to warrant large prospective studies. Medknow Publications & Media Pvt Ltd 2014 /pmc/articles/PMC4093961/ /pubmed/25024938 http://dx.doi.org/10.4103/2229-5151.134150 Text en Copyright: © International Journal of Critical Illness and Injury Science http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Rousseau, Anne-Françoise Bargues, Laurent Bever, Hervé Le Vest, Philippe Cavalier, Etienne Ledoux, Didier Piérard, Gérald E. Damas, Pierre Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients |
title | Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients |
title_full | Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients |
title_fullStr | Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients |
title_full_unstemmed | Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients |
title_short | Effect of gamma-hydroxybutyrate on keratinocytes proliferation: A preliminary prospective controlled study in severe burn patients |
title_sort | effect of gamma-hydroxybutyrate on keratinocytes proliferation: a preliminary prospective controlled study in severe burn patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093961/ https://www.ncbi.nlm.nih.gov/pubmed/25024938 http://dx.doi.org/10.4103/2229-5151.134150 |
work_keys_str_mv | AT rousseauannefrancoise effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients AT bargueslaurent effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients AT beverhervele effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients AT vestphilippe effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients AT cavalieretienne effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients AT ledouxdidier effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients AT pierardgeralde effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients AT damaspierre effectofgammahydroxybutyrateonkeratinocytesproliferationapreliminaryprospectivecontrolledstudyinsevereburnpatients |